Novartis Customer Information
Novartis - Including Sites in Germany
2
0
2
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (2)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Veronica Kon-Jara, MD
Asociación para Evitar la Ceguera en México
Shared therapeutic areas:
Hugo Quiroz-Mercado, MD
Asociación para Evitar la Ceguera en México
Shared therapeutic areas:
Catherine A Cukras, M.D.
National Eye Institute (NEI)
Shared therapeutic areas:
Emily Y Chew, M.D.
National Eye Institute (NEI)
Shared therapeutic areas:
Robert M Hackman, PhD
University of California, Davis
Shared therapeutic areas:
Adriana Solís-Vivanco, MD
Asociación para Evitar la Ceguera en México
Shared therapeutic areas:
Griselda Alvarez-Rivera, MD
Asociación para Evitar la Ceguera en México
Shared therapeutic areas:
Angela M Zivkovic, PhD
University of California, Davis
Shared therapeutic areas:
Sebastian Wolf, MD PhD
University of Bern
Shared therapeutic areas:
Jeffrey S Heier, MD
Ophthalmic Consultants of Boston
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (2)
Showing 2 of 2 trials
Study of Ranibizumab Administered in Conjunction With Photodynamic Therapy With Verteporfin in Patients With Subfoveal Choroidal Neovascularization and Age-Related Macular Degeneration
SUSTAIN - Study of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration
All 2 trials loaded